Dallas, TX: ReportsandReports announce it will carry Bristol-Myers Squibb Co.: PharmaVitae Profile Market Research Report in its Store. Browse complete Bristol-Myers Squibb Co.: PharmaVitae Profile Report Introduction This analysis examines the historical and forecast performance for BMS in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information. Reasons to Purchase Table of Content ABOUT DATAMONITOR HEALTHCARE About the PharmaVitae team Chapter 1 About this profile PharmaVitae Explorer database Chapter structure Executive summary Quarterly update Company introduction Company sales Company financials Key products Data sourcing Sales data Analyst consensus Chapter 2 Executive summary Key findings Prescription pharmaceutical sales and growth rate performance, 2003-15 Financial performance, 2003-15 Bristol-Myers Squibb: PharmaVitae forecasts at a glance Strategic insight Plavix dependency pushes BMS over 2012 patent cliff BMS has the second fastest expiry decline within Big Pharma BMS will focus on areas of high unmet need to mitigate the decline of its CV portfolio BMS builds Big Pharma collaborations Pfizer collaboration for apixaban Antidiabetic collaboration with AstraZeneca BMS fast evolving into a fully-fledged biopharmaceutical player Productivity transformation initiative expected to lower operating costs by $2.5 billion by 2012 Increasingly profitable business model makes BMS an attractive M&A target SWOT analysis Table of Contents Table of figures Chapter 3 Quarterly news update Latest quarterly sales Latest comment Q2 2010 ASCO 2010: ipilimumab achieves breakthrough in ‘long dark tunnel’ of metastatic melanoma ASCO 2010: first-line chronic myeloid leukemia becomes next battleground for Sprycel and Tasigna EASL 2010: promising developments in the hepatitis C pipeline Q1 2010 Slow growth in cardiovascular disease will be offset by prospects in diabetes Latest prescription pharma product news Q3 2010 Q2 2010 Q1 2010 Latest corporate news Q2 2010 Q1 2010 Future product milestones Chapter 4 Company introduction Key findings Background Key corporate developments Bristol-Myers Squibb Bristol-Myers Squibb M&A history Medarex Kosan Biosciences Adnexus Therapeutics Acordis Speciality Fibres DuPont Pharmaceuticals Mead Johnson ConvaTec Medical Imaging Consumer Medicines Oncology Therapeutics Network Corporate restructuring to focus on pharma Chapter 5 Company sales Key findings Prescription pharmaceutical sales and growth rate analysis, 2003-15 Historical analysis Forecast analysis Product analysis Product analysis, 2003-09 Product analysis, 2009-15 Therapy area analysis Geographic analysis Launch/core/expiry analysis Explanation of launch/core/expiry analysis Launch analysis, 2009-15 Core analysis, 2009-15 Expiry analysis, 2009-15 Launch/core/expiry configuration, 2009-15 Molecule type analysis Externalization analysis Chapter 6 Company financials Key findings Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2003-09 Operating costs and profit analysis Operating costs and profit analysis, 2003-09 Operating cost ratio and profit margin analysis, 2003-09 Operating cost ratio and profit margin analysis, 2009-15 Operating costs and profit analysis, 2009-15 Chapter 7 Key products Overview Plavix Summary Sales forecast Reyataz Summary Sales forecast Baraclude Summary Sales forecast Orencia Summary Sales forecast Sprycel Summary Sales forecast Onglyza Summary Sales forecast Erbitux Summary Sales forecast Belatacept Summary Sales forecast Sustiva Summary Sales forecast Ipilimumab Summary Sales forecast Abilify Summary Sales forecast Ixempra Summary Sales forecast Chapter 8 Appendix References Abbreviations Exchange rates About Datamonitor About Datamonitor Healthcare Datamonitor consulting Disclaimer Browse complete Bristol-Myers Squibb Co.: PharmaVitae Profile Report Browse all Healthcare Market Research Reports Browse all Datamonitor Market Research Reports RSS Browse all Latest Report Related Reports: Bristol-Myers Squibb Co.-Deals & Alliances Report Bristol-Myers Squibb Company-Detailed Product Pipeline Bristol-Myers Squibb Company-Therapeutic Competitors About Us: Contact:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/
Posted by
Unknown
on